We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ARAB HEALTH - INFORMA

Download Mobile App




Incisionless Robotic Surgery Benefits Oropharyngeal Cancer Treatment

By HospiMedica International staff writers
Posted on 27 Sep 2016
Print article
Image: The TORS procedure offers a new option for treating oropharyngeal cancer without visible scarring (Photo courtesy Henry Ford Hospital).
Image: The TORS procedure offers a new option for treating oropharyngeal cancer without visible scarring (Photo courtesy Henry Ford Hospital).
TransOral Robotic Surgery (TORS), alone or in conjunction with chemotherapy or radiation may offer oropharyngeal cancer patients good outcomes and survival, according to a new study.

Researchers at Henry Ford Hospital (Detroit, MI, USA) conducted a retrospective study that included 53 oropharyngeal cancer patients (83% male, 77% Caucasian, mean age 60.8 years) who underwent TORS for cancer at the base of tongue, tonsils, soft palate, or pharynx. Among them, 37% underwent TORS alone, 11.4% received additional radiation therapy, and 50% received both chemotherapy and radiation therapy. The majority of patients (63%) were able to receive a lower dose of radiation after TORS, which reduces the risk of radiation side effects.

The researchers identified that 81% of the patients were positive to p16, a marker for human papilloma virus (HPV). When three-year survival, cancer control, and metastasis results were reviewed, patients that were negative to the p16 marker had 100% survival and low cancer recurrence when TORS was the first line of treatment, as well as when TORS was followed by chemotherapy and/or radiation therapy. The study was presented at the American Academy of Otolaryngology-Head and Neck Surgery (AAO-HNS) annual meeting, held during September 2016 in San Diego (CA, USA).

“For non-surgical patients, several studies have shown that p16 positive throat cancers, or HPV- related throat cancers, have better survival and less recurrence than p16 negative throat cancers,” said lead author Tamer Ghanem, MD, PhD, director of head and neck oncology and reconstructive surgery at Surgery at Henry Ford Hospital. “Within our study, patients treated with robotic surgery had excellent results and survival, irrespective of their p16 status.”

TORS is a group of minimally invasive robotic surgery techniques that enable surgeons to remove benign and malignant tumors within the parapharyngeal space, a pyramid-shaped area that lies near the base of the skull and connects several deep compartments of the head and neck. It is lined with many large blood vessels, nerves and complex facial muscles, making access to the space via traditional surgical options often impossible or highly invasive. TORS is performed through the patient's mouth, resulting in shorter, virtually scarless head and neck surgery.

Related Links:
Henry Ford Hospital

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
New
Mattress Replacement System
Carilex DualPlus
New
Mobile Power Procedure Chair
LeMans P360

Print article

Channels

Critical Care

view channel
Image: This handheld scanner is moved over breast tissue to monitor how well breast cancer tumors respond to chemotherapy or radiation treatment (Photo courtesy of Boston University)

Novel Medical Device Inventions Use Light to Monitor Blood Pressure and Track Cancer Treatment Progress

Traditional blood pressure devices often leave room for human error. To address this, scientists at Boston University (Boston, MA, USA) have developed a new blood pressure monitoring device based on speckle... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The acoustic pipette uses sound waves to test for biomarkers in blood (Photo courtesy of Patrick Campbell/CU Boulder)

Handheld, Sound-Based Diagnostic System Delivers Bedside Blood Test Results in An Hour

Patients who go to a doctor for a blood test often have to contend with a needle and syringe, followed by a long wait—sometimes hours or even days—for lab results. Scientists have been working hard to... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.